Except for ARC, GRIK2 and GRID2, belonging to inotropic glutamatergic receptors, were shown to participate in neurodegeneration and psychiatric diseases, such as autism, Huntington disease and major depression [54,55]. Here, GRID2 is linked to juvenile Huntington disease.